Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1087Breast 468Head & Neck 76Tumor-Agnostic 46Other solid neoplasm 46Genitourinary 27CNS 26Thoracic 25Gynecologic 23Endocrine 18NET 12Dermatologic 12Sarcoma 6Lymphoid 6Other neoplasm 4Plasma cell 2Other hematologic neoplasm 2Other 1Myeloid 1Classical hematology 1

Conditions

Obesity 1Neoplasms 1

Interventions

Exercise 27Metformin 24Methods 14Radiotherapy 13Early Intervention, Educational 13Educational Status 12Counseling 12Surveys and Questionnaires 10Standard of Care 10Nutrition Assessment 9Resistance Training 8Diet Therapy 8Cisplatin 8naloxegol 7Tirzepatide 7Diet 7alvimopan 6Psychiatric Rehabilitation 6Fibroblast Growth Factor 7 6Caloric Restriction 6Radiation 5Low-Level Light Therapy 5Liraglutide 5Injections 5Exenatide 5Dexamethasone 5Cryotherapy 5semaglutide 4angiotensin I (1-7) 4Vitamin D 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Capecitabine × Other × Clear all
NCT01828554 2019-11-25

Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight

University of Wisconsin, Madison

Phase NA Completed
8 enrolled 7 charts
Other

Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡